SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000320017-16-000139
Filing Date
2016-07-27
Accepted
2016-07-27 08:44:04
Documents
4
Period of Report
2016-07-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k072716.htm 8-K 30704
2 EXHIBIT 3.1 AMENDED CERTIFICATE exhibit31amendedcertificate.htm EX-3.1 10040
3 EXHIBIT 3.2 AMENDED BYLAWS exhibit32amendedbylaws.htm EX-3.2 7866
4 EXHIBIT 99.1 PRESS RELEASE exhibit991rsspr.htm EX-99.1 12767
  Complete submission text file 0000320017-16-000139.txt   62927
Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920
Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 161785744
SIC: 8090 Services-Misc Health & Allied Services, NEC
Assistant Director 9